YU47192A - Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje - Google Patents

Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje

Info

Publication number
YU47192A
YU47192A YU47192A YU47192A YU47192A YU 47192 A YU47192 A YU 47192A YU 47192 A YU47192 A YU 47192A YU 47192 A YU47192 A YU 47192A YU 47192 A YU47192 A YU 47192A
Authority
YU
Yugoslavia
Prior art keywords
transdermal
pct
substance
procedure
obtaining
Prior art date
Application number
YU47192A
Other languages
English (en)
Inventor
R. Kleinsorgen
Original Assignee
Lts Lohmann Therapie - Sisteme Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie - Sisteme Gmbh. & Co.Kg. filed Critical Lts Lohmann Therapie - Sisteme Gmbh. & Co.Kg.
Priority to HR930663A priority Critical patent/HRP930663B1/xx
Publication of YU47192A publication Critical patent/YU47192A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Steroid Compounds (AREA)

Abstract

TRANSDERMALNI TRETIRAJUĆI SISTEM SA SUPSTANCOM KAO NOSAČEM ZA POTPOMAGANJE TRANSDERMALNE PENETRACIJE I POSTUPAK ZA NJEGOVO DOBIJANJE obuhvata zadnji zaštitni sloj (1,11) nepropusan za aktivnu materiju, na koji je unutar lepljivog sloja (2,12) za pričvršćivanje na kožu nadovezan rezervoar (13) za aktivnu materiju prekriveri folijom (3,15) kao odvojivim zaštitnim slojem, dok supstanca kao nosač sadrži udeo derivata lanolina koji potpomažu penetraciju sainii ili u smeSi sa estrima izopropil alkohola sa dugolančastim masnim kiselinama i/ili polietilenglikoletrima dugolančaštih masnih alkohola. Predmet pronalaska obuhvata i postupak za dobijanje sistema.
YU47192A 1991-05-15 1992-05-05 Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje YU47192A (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HR930663A HRP930663B1 (en) 1991-05-15 1993-04-01 Penetration-promoting substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4115849A DE4115849A1 (de) 1991-05-15 1991-05-15 Penetrationsfoerdernde substanz

Publications (1)

Publication Number Publication Date
YU47192A true YU47192A (sh) 1997-08-22

Family

ID=6431707

Family Applications (1)

Application Number Title Priority Date Filing Date
YU47192A YU47192A (sh) 1991-05-15 1992-05-05 Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje

Country Status (24)

Country Link
US (1) US5492698A (sh)
EP (1) EP0584126B1 (sh)
JP (1) JP2547301B2 (sh)
KR (1) KR100248365B1 (sh)
AT (1) ATE151643T1 (sh)
AU (1) AU658626B2 (sh)
CA (1) CA2103060C (sh)
CZ (1) CZ284034B6 (sh)
DE (2) DE4115849A1 (sh)
DK (1) DK0584126T3 (sh)
ES (1) ES2103369T3 (sh)
FI (1) FI107705B (sh)
GR (1) GR3024015T3 (sh)
HU (1) HU219225B (sh)
IE (1) IE80626B1 (sh)
IL (1) IL101710A (sh)
MY (1) MY131090A (sh)
NO (1) NO306762B1 (sh)
NZ (1) NZ242722A (sh)
PH (1) PH31463A (sh)
SK (1) SK126093A3 (sh)
WO (1) WO1992020378A1 (sh)
YU (1) YU47192A (sh)
ZA (1) ZA923486B (sh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07300419A (ja) * 1993-12-06 1995-11-14 Lansinoh Lab Inc ラノリン／ラノリン酸エステル皮膚処置用組成物
AU4990797A (en) * 1996-10-24 1998-05-15 Alza Corporation Permeation enhancers for transdermal drug delivery compositions, devices, and methods
US6797276B1 (en) 1996-11-14 2004-09-28 The United States Of America As Represented By The Secretary Of The Army Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
US20060002959A1 (en) * 1996-11-14 2006-01-05 Government Of The United States Skin-sctive adjuvants for transcutaneous immuization
US20040258703A1 (en) * 1997-11-14 2004-12-23 The Government Of The Us, As Represented By The Secretary Of The Army Skin-active adjuvants for transcutaneous immunization
DE19834007C1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
WO2000061184A2 (en) * 1999-04-08 2000-10-19 Glenn Gregory M Dry formulation for transcutaneous immunization
EP1372708B1 (en) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
EP1390383B1 (en) * 2001-05-11 2012-02-29 Isis Pharmaceuticals, Inc. Antisense permeation enhancers
EA007956B1 (ru) * 2003-11-05 2007-02-27 Алишир Вейс Оглу Мусаев Способ приготовления препарата на основе нафталановой нефти
US20060124246A1 (en) * 2004-12-14 2006-06-15 Pitney Bowes Incorporated Moistening fluids that destroy and/or inhibit the growth of biological organisms
GB2425475A (en) * 2005-01-29 2006-11-01 Croda Int Plc PEG or PPG lanolin derivatives as antipruritic agents

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
LU62873A1 (sh) * 1971-03-29 1972-12-07
FR2155777A1 (en) * 1971-10-04 1973-05-25 Innothera Lab Sa Mixt of lanolin deriv, lauryl alcohol derivs and polyethylene - glycol - for use as a cosmetic cleansing agent and pharmaceutical exc
US3891757A (en) * 1971-11-11 1975-06-24 Alza Corp Anaesthetic topical and percutaneous administration with selected promoters
US3903256A (en) * 1972-02-07 1975-09-02 Procter & Gamble Compositions for topical application of animal tissue and method of enhancing penetration thereof
US3896238A (en) * 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
US3952099A (en) * 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) * 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4130643A (en) * 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4146649A (en) * 1976-10-14 1979-03-27 Faberge, Incorporated Skin moisturizing composition containing a polyethoxy fatty alcohol and a polyethoxy glycoside
US4335115A (en) * 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
AU520987B2 (en) * 1978-05-08 1982-03-11 Victor Alexander Garten Anti-arthritic preparation
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
SU1090400A1 (ru) * 1982-05-05 1984-05-07 Предприятие П/Я Г-4740 Крем дл кожи лица
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0147883A3 (en) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Aqueous non-aggressive anthelmintic pour-on formulations
JPS6124517A (ja) * 1984-07-11 1986-02-03 Nichiban Co Ltd 循環器疾患用貼布治療製剤
EP0189861A3 (en) * 1985-01-26 1988-02-17 Showa Denko Kabushiki Kaisha Percutaneous absorption accelerator for ionic water-soluble medicine
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
SU1532046A1 (ru) * 1987-08-05 1989-12-30 Научно-производственное объединение "Аэрозоль" Крем дл рук
US5057497A (en) * 1987-11-10 1991-10-15 Calam & Associates, Inc. Oral method for the maintenance of healthy gingival tissues using TRF
DE3807283A1 (de) * 1988-03-05 1989-09-14 Basf Ag Verfahren zur herstellung eines pflasters zur transdermalen anwendung pharmazeutischer wirkstoffe
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions

Also Published As

Publication number Publication date
US5492698A (en) 1996-02-20
FI107705B (fi) 2001-09-28
CZ238093A3 (en) 1994-03-16
NZ242722A (en) 1994-10-26
HUT67321A (en) 1995-03-28
DE59208362D1 (de) 1997-05-22
KR100248365B1 (ko) 2000-04-01
FI935051A0 (fi) 1993-11-15
ATE151643T1 (de) 1997-05-15
WO1992020378A1 (de) 1992-11-26
ES2103369T3 (es) 1997-09-16
NO934107L (no) 1993-11-12
CZ284034B6 (cs) 1998-07-15
MY131090A (en) 2007-07-31
EP0584126B1 (de) 1997-04-16
NO934107D0 (no) 1993-11-12
HU9303230D0 (en) 1994-03-28
IL101710A (en) 1998-03-10
IE921538A1 (en) 1992-11-18
NO306762B1 (no) 1999-12-20
EP0584126A1 (de) 1994-03-02
JPH06503581A (ja) 1994-04-21
AU1670992A (en) 1992-12-30
CA2103060A1 (en) 1992-11-16
FI935051A (fi) 1993-11-15
DK0584126T3 (da) 1997-10-20
JP2547301B2 (ja) 1996-10-23
PH31463A (en) 1998-11-03
GR3024015T3 (en) 1997-10-31
SK126093A3 (en) 1994-09-07
ZA923486B (en) 1993-01-27
HU219225B (en) 2001-03-28
CA2103060C (en) 1999-11-30
AU658626B2 (en) 1995-04-27
IE80626B1 (en) 1998-10-21
DE4115849A1 (de) 1992-11-19
IL101710A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
YU47192A (sh) Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje
AR004483A1 (es) Compuestos para uso en terapia que comprenden un residuo de 1,3-propano diol como agente enlazante entre el residuo de ácido graso y un residuo bioactivo, usos de dichos compuestos y medicamentos , alimentos y formulaciones para el cuidado o tratamiento de la piel que comprenden a dichos compuestos
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ES2060158T3 (es) Uso de alcoholes alifaticos c-22 a c-26 en el tratamiento de enfermedades de la piel inflamatorias y viricas.
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
SE8403487L (sv) Farmaceutisk komposition
DE69809074D1 (de) Herstellung von arzneimitteln
PT781281E (pt) Derivados de beta-carbolina agonistas da melatonina seu processo de preparacao e sua utilizacao a titulo de medicamento
MY104412A (en) Acne treatment.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES522637A0 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation
ES2063440T3 (es) Utilizacion de polisacaridos en preparaciones para el tratamiento de heridas.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
NL185454C (nl) Esterderivaat van een anti-inflammatoir werkzaam carbonzuur, werkwijze voor het bereiden daarvan en farmaceutisch preparaat met anti-inflammatoire werking.
ATE28384T1 (de) Medizinisches verfahren und zubereitung.
ATE164766T1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen
DK138191D0 (da) Salicylsyreholdigt middel til behandling af afskallende hudlidelser
ATE79277T1 (de) Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids.
ES2143940B1 (es) Procedimiento de preparacion selectiva de derivados de alfa-hidroxiacidos.
DE59609482D1 (de) Anellierte beta-carboline
UA19786A (uk) Засіб для обробки бульб кортоплі перед посадкою